middle.news
Clarity Reaches 383 Patients in Pivotal Prostate Imaging Trial
9:14am on Tuesday 27th of October, 2026 AEDT
•
Healthcare
Read Story
Clarity Reaches 383 Patients in Pivotal Prostate Imaging Trial
9:14am on Tuesday 27th of October, 2026 AEDT
Key Points
383 participants dosed in registrational CLARIFY trial
Study tests pelvic lymph-node detection against histopathology
Same-day and next-day imaging performance will be assessed
Topline CLARIFY and AMPLIFY data expected in the first half of 2027
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE